Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
Gilead's first move under new chief is to untether Kite
Biopharma Dive
Fri, 05/3/19 - 10:47 pm
Kite Pharma
Gilead Sciences
CAR-T
Daniel O'Day
Celgene reports 'durable' responses to multiple myeloma CAR-T in early trial despite relapses
Fierce Biotech
Fri, 05/3/19 - 10:45 am
Celgene
Bluebird Bio
bb2121
cell therapy
CAR-T
Multiple Myeloma
Tessa showcases preclinical promise of 'all-in-one' add-on to its cancer cell therapy, in march to the clinic
Endpoints
Fri, 05/3/19 - 10:22 am
Tessa Therapeutics
CAR-T
virally-associated tumors
cancer
cell therapy
How a Medicare Rule Change Could Bring CAR-T Stocks Back to Life
Motley Fool
Sat, 04/27/19 - 10:47 am
Gilead Sciences
Novartis
CMS
Medicare
CAR-T
Kite's CAR-T manufacturing gets another boost with new Maryland facility
Fierce Pharma
Wed, 04/24/19 - 04:07 pm
Gilead Sciences
Kite Pharma
drug manufacturing
Maryland
CAR-T
Medicare proposes raising CAR-T pay, but reimbursement solution years away
Biopharma Dive
Wed, 04/24/19 - 03:58 pm
CMS
CAR-T
Medicare
reimbursement
With some tweaks, CAR-T cancer therapy could be made safer — and more widely available — study suggests
Stat
Mon, 04/22/19 - 07:00 pm
CAR-T
safety
Redesigned CAR-T eliminates dangerous cytokine release syndrome in lymphoma trial
Fierce Biotech
Mon, 04/22/19 - 11:07 am
CAR-T
cytokine release syndrome
CAR-T Drugmaker Poseida Snags $142 Million in Financing Led by Novartis
BioSpace
Mon, 04/22/19 - 10:12 am
Poseida Therapeutics
Novartis
CAR-T
4 Medtech Innovations That Are Tearing up the Script
Medical Devices and Diagnostics Industry
Fri, 04/19/19 - 10:26 am
devices
innovation
neurostimulation
CAR-T
TMVR
machine learning
artificial intelligence
Autolus follows up CAR T data with $101M raise
BioCentury
Thu, 04/11/19 - 10:26 am
Autolus
CAR-T
AUTO1
Eyeing a fast pitch for quick OK in race with bluebird, J&J/Legend team enjoys a regulatory embrace for their rival BCMA CAR-T
Endpoints
Thu, 04/4/19 - 11:53 am
JNJ
Legend Biotech
JNJ-68284528
CAR-T
BCMA
AACR: After blood cancer successes, CAR-T treatments see inroads for solid cancers
Fierce Biotech
Sun, 03/31/19 - 03:39 pm
CAR-T
gene editing
AACR
solid tumors
osteosarcoma
Biotech’s newborn unicorn Sana grabs Harvard tech aimed at slipping engineered stem cells past the immune system
Endpoints
Tue, 03/26/19 - 11:13 pm
Sana Biotechnology
CAR-T
cell therapies
Harvard
Hospitals are saving lives with CAR-T. Getting paid is another story
Stat
Tue, 03/12/19 - 11:30 am
CAR-T
drug pricing
cancer
hospitals
Beyond cancer: CAR T cells treat lupus in mice
BioCentury
Thu, 03/7/19 - 09:30 pm
CAR-T
lupus
Xenetic Biosciences to Acquire Personalized CAR T Platform
CP Wire
Mon, 03/4/19 - 10:18 am
Xenetic Biosciences
CAR-T
Xenetic Biosciences to Acquire Personalized CAR T Platform
Mon, 03/4/19 - 09:59 am
Xenetic Biosciences
CAR-T
Gilead’s Kite pens 10-target CAR-T tech deal with MaxCyte
Fierce Biotech
Sat, 03/2/19 - 12:42 pm
Gilead Sciences
Kite Pharma
CAR-T
MaxCyte
Off-the-shelf CAR-T from stem cells? An early look at UCLA tech — licensed by Gilead
Endpoints
Thu, 02/21/19 - 10:47 pm
CAR-T
Gilead Sciences
UCLA
stem cells
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »